Skip to content

Medifast MED Book value per share

Book value per share at other companies

Eli Lilly logo
Eli LillyLLY
$34.82+98.9%
WW International, Inc. logo
WW International, Inc.WW
$26.57+280%
Herbalife logo
HerbalifeHLF
-$4.07+43.4%
Omada Health, Inc. Common Stock logo
Omada Health, Inc. Common StockOMDA
$3.97+108%
Lifevantage Corporation logo
Lifevantage CorporationLFVN
$2.63+3.0%
The Beachbody Company logo
The Beachbody CompanyBODI
$4.54+30.0%

Other financials

Income statement

See full
Revenue$76.0M-34.3%
Gross profit$51.8M-38.6%
Operating income-$3.3M-161%
Net income-$2.1M-175%
EPS (diluted)-$0.19-171%

Balance sheet

See full
Cash & equivalents$71.5M-22.0%
Total debt$16.1M+10.2%
Total equity$197.7M-6.3%
Total assets$252.0M-10.0%

Cash flow

See full
Operating cash flow$260.0K-92.4%
CapEx$1.1M-28.0%
Free cash flow-$836.0K-144%

Valuation

See full
Market cap$121.87M-17.4%
Enterprise value$66.44M+12.8%
P/S0.4×0.0×

Profitability

See full
Gross margin70.1%-3.8pp
Operating margin-4.7%-7.0pp
Net margin-5.8%-8.1pp
FCF margin5%-9.3pp

Returns & leverage

See full
Return on equity-9.8%-20.1pp
Debt / equity0.1×0.0×
Current ratio4.8×+1.3×

Where this comes from

Calculated from Medifast’s reported figures.

Based on the most recent quarter.

The official record: Medifast’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medifast's book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medifast's book value per share?
Medifast (MED) reported book value per share of $17.96 in Q1 2026.
How has Medifast's book value per share changed year-over-year?
Medifast's book value per share decreased by 6.8% year-over-year, from $19.27 to $17.96.
What is the long-term trend for Medifast's book value per share?
Over 5 years (2020 to 2025), Medifast's book value per share has grown at a 6.4% compound annual growth rate (CAGR), from $13.27 to $18.11.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.